On drug treatment of chronic heart failure patients.docVIP

On drug treatment of chronic heart failure patients Chronic heart failure, also known as congestive heart failure due to chronic decompensated heart failure, there are mostly organs of resistive performance of congestion or congestion, is the final destination of the majority of cardiovascular disease, it is a sufficient venous return under the premise of the heart contraction and (or) diastolic dysfunction, reduced cardiac output, tissue hypoperfusion, the body can not meet the metabolic needs, with the pulmonary circulation and (or) circulation of clinical pathophysiology of congestion syndrome. clinical left The most common heart failure, right heart failure alone is less common. chronic long-term primary cardiomyopathy and ventricular pressure or volume overload, can cause primary or secondary, respectively, systolic and diastolic myocardial function is impaired. In the early days through the generation of compensation adjustment, and can still make ventricular stroke volume and cardiac output to meet tissue metabolism during rest and activity needs, at a later, even if the regulation can not be maintained through the compensatory needs of stroke volume and cardiac output. The former said chronic decompensated heart failure, also known as compensated heart failure or heart failure; which is known as chronic heart failure decompensation, also known as decompensated heart failure or heart failure. 1 Clinical data 1.1 General Information Select September 2006 ~ October 2009 81 patients hospitalized with congestive heart failure patients, 44 males and 37 females, aged 38 to 78 years old. Among them, 37 cases of coronary heart disease, including old myocardial infarction in 9 cases, 8 cases of rheumatic valvular heart disease, hypertensive heart disease was 30 cases of dilated cardiomyopathy in 6 cases. eliminate hypotension, acute myocardial infarction, acute left heart failure and kidney failure cases, we conventional diuretics, β blockers, angiotensi